Paricalcitol

Paricalcitol

SCHEMBL6750666

C[C@H](/C=C/[C@H](C)C(C)(C)O)[C@H]1CC[C@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@]12C.P

nearest known ligand 0.68

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

VDR

The experimentally established mechanism targets of Paricalcitol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
VDR known ✓ P11473 13/20 0.68
HDAC6 Q9UBN7 4/20 0.60
HDAC3 O15379 3/20 0.60
HDAC2 Q92769 2/20 0.60
NR1I2 O75469 2/20 0.57
PGR P06401 2/20 0.57
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
HTR1A P08908 1/20 0.56
ADORA3 P0DMS8 1/20 0.56
SLC6A2 P23975 1/20 0.56
SLC6A4 P31645 1/20 0.56
ADRA1A P35348 1/20 0.56
PTGS2 P35354 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Paricalcitol SCHEMBL12553223 1.00 VDR (0.68) VDRHDAC6HDAC3HDAC2NR1I2
Paricalcitol SCHEMBL12915640 1.00 VDR (0.68) VDRHDAC6HDAC3HDAC2NR1I2
Paricalcitol SCHEMBL12464969 1.00 VDR (0.68) VDRHDAC6HDAC3HDAC2NR1I2
Paricalcitol SCHEMBL12464945 1.00 VDR (0.68) VDRHDAC6HDAC3HDAC2NR1I2
Paricalcitol SCHEMBL25447329 1.00 VDR (0.68) VDRHDAC6HDAC3HDAC2NR1I2
Paricalcitol SCHEMBL21836180 1.00 VDR (0.68) VDRHDAC6HDAC3HDAC2NR1I2
Paricalcitol SCHEMBL24066861 1.00 VDR (0.68) VDRHDAC6HDAC3HDAC2NR1I2
Paricalcitol SCHEMBL13575779 1.00 VDR (0.68) VDRHDAC6HDAC3HDAC2NR1I2
Paricalcitol SCHEMBL3655 1.00 VDR (0.68) VDRHDAC6HDAC3HDAC2NR1I2
Paricalcitol SCHEMBL12397908 1.00 VDR (0.68) VDRHDAC6HDAC3HDAC2NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040048837-A1 Administering paricalcitol in place of calcitriol, preferably without regard to the secondary hyperparathyroidism, calcium or phosphate status FRESENIUS USA, INC. 2004-03-11 US disclosed